Does Dr. Follows study issues related to vaccines?

Yes, Dr. Follows conducts research on vaccine adverse events and their implications, especially concerning serious conditions like Guillain-Barré syndrome.

What treatments has Dr. Follows researched?

He has researched the effectiveness of cyclosporine, an immunosuppressive drug, in dogs and has developed a test to evaluate its performance.

Is Dr. Follows' work relevant to dog owners?

Absolutely. His research helps dog owners by improving the management of immunosuppressive therapies tailored for their pets.

Who benefits from Dr. Follows' research on vaccine adverse events?

Patients who suffer from negative side effects after vaccination benefit from his work, especially those needing support through compensation processes.

How does Dr. Follows’ veterinary research impact clinical practices?

His findings contribute to better clinical practices in veterinary medicine, allowing veterinarians to customize medication dosages more effectively for dogs.

DR. JOHN WILLIAM FOLLOWS JR., M.D.

SPENCER, IA

Research Active

Orthopaedic Surgery NPI registered 21+ years 7 publications 1987 – 2014 NPI: 1508869413

Orthopaedic Surgery

Immunosuppressive Agents Malpractice Dogs Guideline Adherence T-Lymphocytes Interleukin-2 Interferon-gamma Reverse Transcriptase Polymerase Chain Reaction Nursing Staff, Hospital Craniocerebral Trauma Compensation and Redress Antibiotic Prophylaxis Evidence-Based Practice Vasectomy Guillain-Barre Syndrome

Practice Location

1200 1ST AVE E
SPENCER, IA 51301-4342

Phone: (712) 262-7511

What does JOHN FOLLOWS research?

Dr. Follows conducts research in two main areas: veterinary immunology and vaccine safety. In his veterinary studies, he developed a new test that helps veterinarians measure how well a drug called cyclosporine works in dogs by analyzing immune system markers. This is important because it allows for personalized medication plans to better serve each dog's needs. Additionally, his work on vaccine adverse events investigates the negative side effects some individuals might experience after receiving vaccines, particularly linking it to conditions like Guillain-Barré syndrome. This research is crucial in helping affected individuals navigate compensation processes after experiencing vaccine-related injuries.

Key findings

Dr. Follows' test for evaluating cyclosporine effectiveness in dogs was validated with reliable results, regardless of whether blood samples were stored at room temperature or refrigerated for two days.
His research on vaccine adverse events highlighted the connection between the seasonal flu vaccine and Guillain-Barré syndrome, ensuring better awareness of potential risks.
The study regarding vaccine injuries provides a clear pathway for patients to claim compensation, helping them access support after negative health impacts.

Frequently asked questions

Does Dr. Follows study issues related to vaccines?: Yes, Dr. Follows conducts research on vaccine adverse events and their implications, especially concerning serious conditions like Guillain-Barré syndrome.
What treatments has Dr. Follows researched?: He has researched the effectiveness of cyclosporine, an immunosuppressive drug, in dogs and has developed a test to evaluate its performance.
Is Dr. Follows' work relevant to dog owners?: Absolutely. His research helps dog owners by improving the management of immunosuppressive therapies tailored for their pets.
Who benefits from Dr. Follows' research on vaccine adverse events?: Patients who suffer from negative side effects after vaccination benefit from his work, especially those needing support through compensation processes.
How does Dr. Follows’ veterinary research impact clinical practices?: His findings contribute to better clinical practices in veterinary medicine, allowing veterinarians to customize medication dosages more effectively for dogs.

Publications in plain English

Instructional video on vasectomy: evidence-based procedure should be demonstrated.

2014

Canadian family physician Medecin de famille canadien

Labrecque M, Weiss R, Pollock N, Bernier M, Bernier Y +11 more

PubMed

Analytical validation of a quantitative reverse transcriptase polymerase chain reaction assay for evaluation of T-cell targeted immunosuppressive therapy in the dog.

2013

Veterinary immunology and immunopathology

Riggs C, Archer T, Fellman C, Figueiredo AS, Follows J +4 more

Plain English
This study examined a new test designed to measure how effective cyclosporine, an immunosuppressive drug, is in dogs by looking at specific immune markers. The researchers found that the test performed reliably whether the blood samples were stored at room temperature or in the fridge for up to two days. This matters because it allows veterinarians to better tailor cyclosporine treatment for individual dogs and ensure they receive the correct dosage. Who this helps: This helps veterinarians and dog owners manage immunosuppressive therapy more effectively.

PubMed

Vaccine adverse events.

2012

Workplace health & safety

Follows J

Plain English
This study looked at the negative effects some people experience after getting the seasonal flu vaccine, specifically focusing on cases of a serious condition known as Guillain-Barré syndrome. It explains how individuals who suffer from verified vaccine injuries can apply for financial compensation through a special court system set up for this purpose. Understanding these claims helps ensure that those affected receive the support they need after vaccination. Who this helps: This helps patients who experience adverse effects from vaccines.

PubMed